Naloxone-induced reduction of schizophrenic symptoms
- PMID: 6126068
- DOI: 10.1111/j.1600-0447.1982.tb00858.x
Naloxone-induced reduction of schizophrenic symptoms
Abstract
A schizophrenic patient was repeatedly treated with intravenous naloxone 0.04 mg or saline in a double-blind design. The Comprehensive Psychopathological Rating Scale was used to quantify the symptoms before and after each injection. Naloxone significantly reduced the symptoms temporarily, whereas saline was without effect.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
